Skip to Main Content
Contribute Try STAT+ Today

WASHINGTON — President Trump on Monday signed an executive order directing federal agencies to cut two regulations for every new one that they adopt, a move that could have significant implications for the Food and Drug Administration.

Trump, who vowed throughout his campaign to ease the burden of government regulations in order to promote innovation, pledged at the signing ceremony that the order would be “the biggest such act our country has ever seen.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • THIS Cures Act is not helping us with infused gamma globulin that saves our lives with immune deficiencies. I must have this to live. I must have it done in a relaxed setting without germs, viruses etc. I am immune deficient. The infusion is not active for 3 days says my oncologist. I am not able to take it any more frequently; not recommended as I am chemical sensitive and live well on this infused blood product. According to the survey, this home infusion is far cheaper than done in a hospital; which is not wise for several reasons. Medicare saves about half the money if done at home and pharmacies do not want to use IVIG gamma globulin any longer due to the Cures Act of January 1, 2017. It is a financial risk for them now; it created a profit magin that is too low. I have called 12 pharmacies and am told they nolonger carry it for this reason yet I am approved for it again due to my CMS letter of Nov 3, 2017. What can you do to correct this? I am a very active 73 yr old and write books people may need to get well. AND Medicare approved under part B (most desirable) and part D.

    Pharmacies contacted:
    Premier – sub Q only
    Option Care
    Infusion of Care
    RESPECTFULLY, linda steele loving life!…..this Cures Act could take my life

Comments are closed.